Free Trial

BioAge Labs (BIOA) SEC Filings & 10K Form

BioAge Labs logo
$5.61 -0.29 (-4.92%)
As of 04:00 PM Eastern

Recent BioAge Labs SEC Filings

DateFilerForm TypeView
08/14/2025
7:07 PM
ADAR1 Capital Management, LLC (Filed by)
BioAge Labs (Subject)
Form SCHEDULE 13G
08/14/2025
2:01 PM
BioAge Labs (Subject)
Cormorant Asset Management, LP (Filed by)
Form SCHEDULE 13G/A
08/06/2025
3:35 PM
BioAge Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
3:41 PM
BioAge Labs (Issuer)
GARNIER JEAN PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:42 PM
BioAge Labs (Issuer)
Davidson Michael H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:44 PM
BioAge Labs (Issuer)
ENRIGHT PATRICK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:46 PM
BioAge Labs (Issuer)
HEALY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:47 PM
BioAge Labs (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
8:00 AM
BioAge Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
3:35 PM
BioAge Labs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
3:05 PM
BioAge Labs (Filer)
Form DEF 14A
04/17/2025
3:10 PM
BioAge Labs (Filer)
Form DEFA14A
03/20/2025
4:23 PM
BioAge Labs (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
3:28 PM
BioAge Labs (Issuer)
Morgen Eric (Reporting)
Form 4/A
02/20/2025
3:19 PM
BioAge Labs (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:21 PM
BioAge Labs (Issuer)
Morgen Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:22 PM
BioAge Labs (Issuer)
RUBIN PAUL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:27 PM
BioAge Labs (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
2:00 PM
BioAge Labs (Subject)
Cormorant Asset Management, LP (Filed by)
Form SCHEDULE 13G
11/07/2024
3:40 PM
BioAge Labs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2024
7:21 PM
AH Bio Fund I, L.P. (Filed by)
BioAge Labs (Subject)
Form SC 13D
10/03/2024
6:19 PM
BioAge Labs (Issuer)
Pande Vijay Satyanand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIOA) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners